Hypothesis: The histopathologic correlation between stereotactic core needl
e biopsy and subsequent surgical excision of mammographically detected nonp
alpable breast abnormalities is improved with a larger-core (11-gauge) devi
ce.
Design: Retrospective medical record and histopathologic review.
Setting: University-based academic practice setting.
Patients: Two hundred one patients who underwent surgical excision of mammo
graphic abnormalities that had undergone biopsy with an 11-gauge vacuum-ass
isted stereotactic core biopsy device.
Main Outcome Measure: Correlation between stereotactic biopsy histologic re
sults and the histologic results of subsequent surgical specimens.
Results: Results of stereotactic biopsy performed on 851 patients revealed
atypical hyperplasia in 46 lesions, ductal carcinoma in situ (DCIS) in 89 l
esions, and invasive cancer in 73 mammographic abnormalities. Subsequent su
rgical excision of the 46 atypical lesions revealed 2 cases of DCIS (4.3%)
and 4 cases of invasive carcinoma (8.7%). Lesions diagnosed as DCIS on ster
eotactic biopsy proved to be invasive carcinoma in 10 (11.2%) of 89 patient
s on subsequent excision. Stereotactic biopsy completely removed 21 (23.6%)
of 89 DCIS lesions and 20 (27.4%) of 73 invasive carcinomas.
Conclusions: In summary, 11-gauge vacuum-assisted core breast biopsy accura
tely predicts the degree of disease in the majority of malignant lesions; h
owever, understaging still occurs in 11% to 13% of lesions showing atypical
hyperplasia or DCIS.